Pineridge Advisors’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-7
Closed -$489 – 513
2024
Q4
$489 Hold
7
– – ﹤0.01% 572
2024
Q3
$734 Hold
7
– – ﹤0.01% 516
2024
Q2
$995 Hold
7
– – ﹤0.01% 526
2024
Q1
$781 Sell
7
-34
-83% -$4.05K ﹤0.01% 535
2023
Q4
$5.32K Buy
+41
New +$5.65K ﹤0.01% 481

Other funds holding ACLS

Pineridge Advisors's ACLS Position: Q1 2025 in Review

Pineridge Advisors sold out of Axcelis (ACLS) in Q1 2025, closing a stake of 7 shares — an estimated $489 sold.

Pineridge Advisors first reported a position in ACLS in Q4 2023 and held it in 5 quarters. The position peaked at $5.32K in Q4 2023. 307 funds tracked by Wall St. Rank hold ACLS as of Q1 2025.

  • Pineridge Advisors reported no remaining Axcelis position as of Q1 2025 after selling out during the quarter.
  • Pineridge Advisors sold 7 Axcelis shares in Q1 2025, an estimated $489.
  • Pineridge Advisors first reported a position in Axcelis in Q4 2023 and held it in 5 quarters.
  • Pineridge Advisors's Axcelis position peaked at $5.32K in Q4 2023.
  • 307 funds tracked by Wall St. Rank held Axcelis as of Q1 2025.

Based on Pineridge Advisors's 13F filing for Q1 2025, filed 30 Apr 2025.